ASBP
Aspire Biopharma Holdings, Inc.
Key Financials
Net Income
$-24480848
↓ 95.3%
Revenue
$6202
N/A
Gross Profit
$-116
N/A
Operating Income
$-19351291
↓ 1498.1%
EPS (Diluted)
$-16.38
↓ 762.1%
Total Liabilities
$7.7M
↓ 50.8%
Total Assets
$1.3M
↓ 80.5%
Shareholders' Equity
$-6376329.00
↑ 59.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G | 7/2/2026 | View on SEC |
| 8-K | 6/22/2026 | View on SEC |
| 8-K | 6/12/2026 | View on SEC |
| 8-K | 6/12/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| 8-K | 5/14/2026 | View on SEC |
| SCHEDULE 13G/A | 5/13/2026 | View on SEC |
| DEFR14A | 5/12/2026 | View on SEC |
| DEF 14A | 5/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ASBP |
| Company Name | Aspire Biopharma Holdings, Inc. |
| CIK | 1847345 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | E9 |
| Phone | 561-704-8527 |